Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03767257 · OUTCOME

Number of Participants With GI Symptom Assessment

A Study of Colesevelam for Lenalidomide-Associated Diarrhea · Source last updated 2025-10-21

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
4 weeks

What was measured

To assess GI symptoms using Patient Reported Outcomes within the Common Terminology Criteria for Adverse Events

Groups in this outcome

Participants With Myeloma

Individuals with Myeloma on lenalidomide maintenance who experience grade 2 or more diarrhea

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Participants With Myeloma25

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Participants With Myeloma25Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        25
denoms
  1. counts
    1. group Id
      OG000
      value
      25
    units
    Participants
description
To assess GI symptoms using Patient Reported Outcomes within the Common Terminology Criteria for Adverse Events
groups
  1. description
    Individuals with Myeloma on lenalidomide maintenance who experience grade 2 or more diarrhea
    id
    OG000
    title
    Participants With Myeloma
param Type
COUNT_OF_PARTICIPANTS
reporting Status
POSTED
time Frame
4 weeks
title
Number of Participants With GI Symptom Assessment
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice